Shares of Chembio Diagnostics (CEMI +4.2%) moves higher after the USDA approves its CervidTB...


Shares of Chembio Diagnostics (CEMI +4.2%) moves higher after the USDA approves its CervidTB STAT-PAK and DPP VetTB test kits as primary and secondary tests for bovine tuberculosis by the USDA Animal and Plant Health Inspection Service. The approval was made in order to provide the farmed deer industry with more options for meeting testing requirements for captive elk and deer.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs